ArticleMolecular and clinical oncology2021

Predictive factors associated with relapse of stage II/III colon cancer treated with peroral anti-cancer agents in the adjuvant setting.

Yusuke Mizuuchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.